Kelonia is a company working on genetic medicine, using their Kelonia Therapeutics Platform with iGPS® technology to efficiently deliver genetic cargo to desired tissues.

Kelonia

Kelonia is pioneering a new wave of genetic medicines using its next generation gene delivery platform. The company’s simple and elegant cutting-edge in vivo gene delivery technology uses a few potent lentiviral vector-like particles to precisely and efficiently deliver in vivo genetic cargo to the desired target tissue, and only that tissue, every time. With an initial focus on developing transformational therapies for solid tumors and hematologic cancers, Kelonia is building a pipeline of genetic medicines for a wide range of diseases, with the bold goal of bringing genetic medicines to every patient in need.

Venrock

Horizons Ventures

Alta Partners

Kelonia Therapeutics

Last month, we had the privilege of hosting Dr. Kristen Hege, Kelonia board member and trailblazer in the field of cell therapy, for an inspiring leadership talk!
 
Dr. Hege shared profound insights from her journey hiking the Pacific Coast Trail, drawing compelling parallels to her pioneering work in CAR T-cell therapies. Her reflections on leadership, perseverance, and embracing challenges left a lasting impact on all who attended and continues to resonate with our team as we continue our work advancing our own lead in vivo CAR T program to the clinic.

We had a blast partnering with teammates from Special Olympics Massachusetts at last week’s Bio-Ball 2024 fundraiser and basketball tournament. We came together to #playunified and raise money for a great cause alongside our biotech industry peers. Team Kelonia proudly raised $16,378 for Special Olympics Massachusetts, putting us in 3rd place in the fundraising challenge, and securing our chance to play on the parquet floor at TD Garden with our teammates from Special Olympics Lynn & Haverill!  
 
Learn more about how you can support: https://lnkd.in/gBB2QkVP.  #ChooseToInclude #PlayUnified

We look forward to presenting preclinical data from our lead #invivo #CART candidate, KLN-1010, in #MultipleMyeloma at the American Association for Cancer Research Annual Meeting 2024 in San Diego. Stop by our poster presentation to learn more about the therapeutic potential of KLN-1010 and the promise of our iGPS® technology for #geneticmedicines.  
 
See details of our poster here: https://lnkd.in/gYq-Pz6f 
 
#AACR24

Our #2023HolidayParty was last week, after the holidays! This not only gave us something to look forward to in January, but it also allowed us to really let our hair down because it's a (slightly) less hectic time than the holidays. Congratulations to Jose Sanabria and Joshua Daniel, the winners of our ugly sweater contests!  Huge thanks to our neighbors, Capo Restaurant & Supper Club, for hosting us! It was a beautiful location with delicious food, and we had a great time!

Our Vice President, Strategy and Business Development, Bharat Reddy, is attending Biotechnology Innovation Organization’s #BIO2024. Connect with us in sunny San Diego, to learn more about our iGPS® platform exciting work advancing #invivo CAR-T therapies for cancer: https://lnkd.in/eEDtKaAK.

#HappyNewYear! We kicked off 2024 by bringing donations from our 2nd annual clothing drive to St. Francis House. Please consider donating new or gently-used clothes to your local shelter (especially outerwear!) to help your unhoused neighbors keep warm during these cold winter months.

news_impact_assignment_basic

key_people

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

merger_acquisitions

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Jul 24, 2024 6:06 AM	609af33c
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general
crunchbase trigger	general	Nov 11, 2024 10:30 AM	1dc85e4c
crunchbase profile	general
li profile	general	Jul 24, 2024 6:06 AM	033983d7
translate crunchbase fundingrounds	general
peers	general	Jul 24, 2024 6:06 AM	337b2212
news basic	general	Jul 24, 2024 6:06 AM	f1fe5ad5
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

KELO

COM:KELONIATX

Kelonia